International Clinical Trial: A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136987) titled 'A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery' on Aug. 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Open Source Pharma Foundation

Condition: Tuberculosis

Intervention: Drug: Metformin Dietary Supplement: N-Acetylcysteine (NAC) Treatment

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: January 2026

Target Sample Size: 1104

To know more, visit https://clinicaltrials.gov/ct2...